.RESEARCH HIGHLIGHT.06 August 2024.
A large randomized controlled test with cisgender women highlights the problems of obedience to a daily dental preexposure treatment program and also displays that twice-yearly treatment of lenacapavir can easily keep helpful HIV avoidance levels over 6 months.